Nurix Therapeutics (NRIX) EBIT Margin Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 3,609.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1,536.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -170.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -3,724.00 |
| 10 | Nurix Therapeutics | 1.95 Bn | 1.41 Bn | - | -113,878.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -113,878.00 |
| Nov 30, 2025 | -12,530.00 |
| Aug 31, 2025 | -72,382.00 |
| May 31, 2025 | 7,928.00 |
| Feb 28, 2025 | -6,802.00 |
| Nov 30, 2024 | -18,767.00 |
| Aug 31, 2024 | -21,717.00 |
| May 31, 2024 | -31,417.00 |
| Feb 29, 2024 | 6,595.00 |
| Nov 30, 2023 | 41,877.00 |
| Aug 31, 2023 | 21,627.00 |
| May 31, 2023 | 31,264.00 |
| Feb 28, 2023 | 10,567.00 |
| Nov 30, 2022 | -20,467.00 |
| Aug 31, 2022 | -15,009.00 |
| May 31, 2022 | -2,739.00 |
| Feb 28, 2022 | 4,509.00 |
| Nov 30, 2021 | -21,404.00 |
| Aug 31, 2021 | 18,697.00 |
| May 31, 2021 | -5,614.00 |
| Feb 28, 2021 | -5,106.00 |
| Nov 30, 2020 | 42,935.00 |
| Aug 31, 2020 | -44,513.00 |